Liver-Targeted Prodrugs of 2‘-C-Methyladenosine for Therapy of Hepatitis C Virus Infection-Reference-Cited by-同舟云学术

Liver-Targeted Prodrugs of 2‘-C-Methyladenosine for Therapy of Hepatitis C Virus Infection

Published:2007-07-18 Issue:16 Volume:50 Page:3891-3896
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Hecker Scott J.¹,Reddy K. Raja¹,van Poelje Paul D.¹,Sun Zhili¹,Huang Wenjian¹,Varkhedkar Vaibhav¹,Reddy M. Venkat¹,Fujitaki James M.¹,Olsen David B.¹,Koeplinger Kenneth A.¹,Boyer Serge H.¹,Linemeyer David L.¹,MacCoss Malcolm¹,Erion Mark D.¹

Affiliation:

1. Departments of Biochemistry and Medicinal Chemistry, Metabasis Therapeutics, Inc., 11119 North Torrey Pines Road, La Jolla, California 92037, Departments of Antiviral Research and Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, and Department of Chemistry, Merck Research Laboratories, Rahway, New Jersey 07065

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0701021

Reference19 articles.

1. Global epidemiology of hepatitis C virus infection

2. Nucleoside Analog Inhibitors of Hepatitis C Virus Replication

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and biological evaluation of Ribo 7-N/O/S pyrimidine 9-deaza C-nucleoside analogs as new antiviral agents for inhibiting HCV RNA-dependent RNA polymerases;European Journal of Medicinal Chemistry;2024-01

2. Synthesis of novel azasugar-containing 2'β-C-Me 9-deaza nucleosides as potential anti-hepatitis C virus agents;Nucleosides, Nucleotides & Nucleic Acids;2022-11-10

3. Cyanoacetylenic Alcohols: Molecules of Interstellar Relevance in the Synthesis of Essential Heterocycles, Amino Acids, Nucleobases and Nucleosides;Synthesis;2021-04-28

4. Development of a Novel Chemoenzymatic Process for (S)-1-(Pyridin-4-yl)-1,3-propanediol;Organic Process Research & Development;2020-11-25

5. Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors;Journal of Medicinal Chemistry;2017-01-31